← Back to Search

Nausea Relief Inhaler for Post-Operative Nausea and Vomiting

N/A
Recruiting
Led By Ashley Attaway, RN
Research Sponsored by Methodist Health System
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 to 65 years old
Admitted to B4 surgical acute unit
Must not have
BMI greater than 60
Timeline
Screening 3 weeks
Treatment Varies
Follow Up duration of hospital stay: date of discharge minus date of admittance)
Awards & highlights
No Placebo-Only Group

Summary

This trial suggests that a nausea relief inhaler could reduce post-op nausea and vomiting after bariatric surgery, improving patient satisfaction and ability to ambulate.

Who is the study for?
This trial is for individuals aged 18 to 65 who are undergoing bariatric surgery after May 31st, 2020. Participants must attend a pre-op class and read English. It's not for those on pre-op nausea meds, with a BMI over 60, allergies to certain natural scents, or with asthma/COPD.
What is being tested?
The study tests if a nausea relief inhaler can reduce post-operative nausea and vomiting in patients after bariatric surgery. The goal is to see if this method decreases the need for additional medications and improves patient recovery experience.
What are the potential side effects?
Potential side effects of the nausea relief inhaler may include reactions to its natural ingredients like spearmint, lemon, ginger, or cedarwood. However, these are expected to be minimal compared to traditional medication.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.
Select...
I am admitted to the B4 surgical acute unit.
Select...
I will attend the pre-operative class.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
My BMI is over 60.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~"up to 24 hours"
This trial's timeline: 3 weeks for screening, Varies for treatment, and "up to 24 hours" for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Medication Administration Record
Secondary study objectives
Length of stay
Rhodes index

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: AromatherapyExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Methodist Health SystemLead Sponsor
155 Previous Clinical Trials
4,825,496 Total Patients Enrolled
Ashley Attaway, RNPrincipal InvestigatorMethodist Mansfield Medical Center
~10 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top